RhoA is required for monocyte tail retraction during transendothelial migration

Area of Science:

• Cell Biology
• Immunology
• Molecular Biology

Background:

• Transendothelial migration is crucial for monocytes to enter tissues.
• This process involves dynamic changes in cell shape and adhesion, regulated by cytoskeletal dynamics.
• The role of RhoA in these cytoskeletal reorganizations during monocyte extravasation was unclear.

Purpose of the Study:

• To investigate the function of RhoA in cytoskeletal dynamics during monocyte transendothelial migration.
• To determine the specific steps of extravasation where RhoA is required.
• To identify downstream effectors of RhoA involved in monocyte transmigration.

Main Methods:

• Monocytes were loaded with C3, a RhoA inhibitor.
• Transendothelial migration was assessed using various microscopy techniques, including time-lapse video microscopy.
• The role of p160ROCK, a RhoA effector, was examined.

Main Results:

• RhoA is required for transendothelial migration, but not for initial monocyte attachment or spreading on endothelium.
• RhoA-inhibited monocytes exhibited impaired tail retraction and incomplete diapedesis.
• p160ROCK is necessary and sufficient for RhoA-mediated tail retraction and negatively regulates integrin adhesions.

Conclusions:

• RhoA signaling is critical for the final stages of monocyte extravasation, specifically tail retraction.
• p160ROCK mediates RhoA's function in tail retraction by regulating integrin adhesions.
• Understanding RhoA's role provides insight into immune cell trafficking and inflammatory responses.